Operating Margin of Allogene Therapeutics, Inc. from 31 Mar 2021 to 31 Dec 2024

Taxonomy & unit: ratio: %
Description: The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary: Allogene Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Mar 2021 to 31 Dec 2024.
Allogene Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2024 was -1241814%, a 260% decline year-over-year.
Allogene Therapeutics, Inc. annual Operating Margin for 2024 was -1241814%, a 260% decline from 2023.
Allogene Therapeutics, Inc. annual Operating Margin for 2023 was -344986%, a 60% decline from 2022.
Allogene Therapeutics, Inc. annual Operating Margin for 2022 was -215087%, a 136083% decline from 2021.

Operating Margin, Quarterly (%)

Operating Margin, YoY Quarterly Change (%)

Operating Margin, Annual (%)

Operating Margin, YoY Annual Change (%)

Allogene Therapeutics, Inc. Quarterly Operating Margin (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q4 2024	-1241814%	-896827%	-260%	01 Oct 2024	31 Dec 2024
Q3 2024	-692600%	-353577%	-104%	01 Jul 2024	30 Sep 2024
Q2 2024	-444677%	-103212%	-30%	01 Apr 2024	30 Jun 2024
Q1 2024	-342700%	-101466%	-42%	01 Jan 2024	31 Mar 2024
Q4 2023	-344986%	-129899%	-60%	01 Oct 2023	31 Dec 2023
Q3 2023	-339023%			01 Jul 2023	30 Sep 2023
Q2 2023	-341465%			01 Apr 2023	30 Jun 2023
Q1 2023	-241234%			01 Jan 2023	31 Mar 2023
Q4 2022	-215087%			01 Oct 2022	31 Dec 2022
Q3 2021	-654%			01 Jul 2021	30 Sep 2021
Q2 2021	-629%			01 Apr 2021	30 Jun 2021
Q1 2021	-610%			01 Jan 2021	31 Mar 2021

Period	Value	YoY Chg	Change %	Start Date	End Date
2024	-1241814%	-896827%	-260%	01 Jan 2024	31 Dec 2024
2023	-344986%	-129899%	-60%	01 Jan 2023	31 Dec 2023
2022	-215087%	-214929%	-136083%	01 Jan 2022	31 Dec 2022
2021	-158%			01 Jan 2021	31 Dec 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.